Head-to-head · WeighScore
Eve vs HealthRX
By GLP-1 ScorecardUpdated
Score comparison
HealthRX has the higher recorded score — 77.5/100 to 66.3/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.
Before you choose
Eve does not publish a semaglutide price, so its Eve review sets out what it does disclose, while the HealthRX review explains the conditions attached to HealthRX's figure. The semaglutide cost page compares published rates across the field. Ask Eve for a written total before treating either one as the cheaper choice.
If neither one fits, Eve vs RxSpan MD and EverSlim vs HealthRX compare each of them with another graded program, and the list of alternatives to Eve ranks the programs closest to Eve on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Eve | HealthRX |
|---|---|---|
| WeighScore | 66.3/100 | 77.5/100 |
| Grade | C | C+ |
| Site position | #206 | #34 |
| Semaglutide | Current price not verified | $39 first month, then $125/month on a 3-month plan ($115 on 6 months, $97 on 12); month to month $109 first month, then $139/month |
| Tirzepatide | Current price not verified | $39 first month, then $219/month on a 3-month plan ($179 on 6 months, $159 on 12); month to month $109 first month, then $239/month |
| Coverage | Confirm coverage for your state | All 50 states claimed; subject to clinical eligibility |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Homepage lists Wegovy, Ozempic and Mounjaro
- Terms identify Eve Health, Inc. and describe third-party care
What to consider
- Current compounded prices and plan-specific cancellation terms remain unverified
Strengths
- First payment and recurring monthly charge shown together for every plan
- Medication if prescribed, review, instructions and overnight shipping included; no separate GLP-1 membership fee stated
- A month-to-month option carries no minimum term
- Full refund promised if clinical approval is declined
What to consider
- On 3-, 6- and 12-month plans the remaining monthly payments stay due after an early cancellation
- Assigned medical practice and dispensing pharmacy not named on reviewed public pages
- Refund promises for unshipped doses need reconciliation with restrictions after dispensing
- Injection supplies, clinical response time and monitoring cadence unconfirmed
Featured provider
HealthRX
Factor scores not reassessed.HealthRX scores 77.5/100 (C+). HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.